- CSR Summary Not Yet Available
- NCT00210808
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment407% Female84.2%% White75.7%
Product ClassAnticonvulsantsSponsor Protocol NumberCAPSS-220Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)44
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Clinical Study Report Available